Medical societies representing all three specialties issued a joint statement Jan. 21, criticizing studies claiming such scans pose risk of potential patient harm.
The Healthcare Leadership Council—a forum for C-suite leaders across different industries—recently released the results of a new survey of its members.
Imaging experts advocate for “meticulous assessments” of cases that include luminal cancer, dense breasts, and lesions located outside the mammary zone, among other factors.
"We were pleased to see a partial restoration of the PTET deduction, but we will continue to fight for the full deduction before the bill reaches the president’s desk," one lobbyist tells Radiology Business.
Dana Smetherman, MD, CEO of the ACR, explains a resolution adopted at the American Medical Association House of Delegates meeting calling for new health IT standards.
Thanks to AI, clinicians can use mammograms to do a lot more than identify signs of breast cancer. Researchers explored data from nearly 50,000 patients, presenting their findings in Heart.